Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. (Q35997118)

11 August 2017

1 reference

title

Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. (English)

1 reference

inflammatory bowel diseases

11 August 2017

main subject

0 references

author name string

Arianne L Theiss

series ordinal

1 reference

11 August 2017

Shira Fruchtman

series ordinal

1 reference

11 August 2017

P Kay Lund

series ordinal

1 reference

11 August 2017

publication date

1 November 2004

1 reference

Inflammatory Bowel Diseases

11 August 2017

published in

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

871-880

1 reference

Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Surgical therapy for ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Surgery for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Insulin-like growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Normal growth and development in the absence of hepatic insulin-like growth factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

The molecular basis of growth hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

STAT5b is required for GH-induced liver IGF-I gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

IGF-I receptor signalling in transformation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth hormone stimulates, through tyrosine kinase, ion transport and proliferation in human intestinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

The effect of hypophysectomy on the gastrointestinal tract. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth failure and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1phase cell cycle proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Regulation of migration of human colonic myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

The growth hormone-insulin-like growth factor-I axis and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Inhibitors of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Suppressors of cytokine signaling and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Gigantism in mice lacking suppressor of cytokine signalling-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS3 negatively regulates IL-6 signaling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS3 regulates the plasticity of gp130 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Regulation of cytokine signaling by SOCS family molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth Enhancement in Suppressor of Cytokine Signaling 2 (SOCS-2)-Deficient Mice Is Dependent on Signal Transducer and Activator of Transcription 5b (STAT5b)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200411000-00021

10.1097/00054725-200411000-00021

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference